LYONS GARY A
5 of 9 shown
The 5 most recent of 9 visible filings, newest first.
- Travere Therapeutics, Inc. Director5,000 sharesOption exercise
- Travere Therapeutics, Inc. Director$57,470Open-market sale
- Travere Therapeutics, Inc. Director$259,390Open-market sale
- Travere Therapeutics, Inc. Director$87,200Option exercise
- Travere Therapeutics, Inc. Director5,000 sharesOption exercise